|
Ocrelizumab (US) Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: Ocrevus
Mobile, Alabama1 trial
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
University of South Alabama
Phase 3
Chicago, Illinois1 trial
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
Northwestern Memorial Hospital
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.